Estimations des analystes de Wall Street pour Profound Medical Corp. (PROF): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.23 | ||
| 2026-08-06 | $-0.26 | $-0.22 | -18.2% |
| 2026-05-07 | $-0.19 | $-0.24 | +20.8% |
| 2026-03-05 | $-0.27 | $-0.27 | +0.0% |
| 2025-11-13 | $-0.26 | $-0.38 | +31.6% |
| 2025-08-14 | $-0.52 | $-0.43 | -20.9% |
| 2025-05-08 | $-0.36 | $-0.29 | -24.1% |
| 2025-03-06 | $-0.20 | $-0.31 | +35.5% |
Ratios de valorisation
| Prix / Valeur comptable | 4.10 |
| EV / EBITDA | -5.25 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | 0 | $4.9M | $1.9M | $4.2M | $7.3M | $6.9M | $6.7M | $7.2M | $10.2M | $16.4M |
| Coût des Ventes | $188385 | $3.0M | $1.3M | $1.8M | $3.8M | $3.9M | $3.7M | $2.8M | $3.5M | $4.8M |
| Marge Brute | -$188385 | $1.9M | $604815 | $2.4M | $3.5M | $3.0M | $3.0M | $4.4M | $6.7M | $11.6M |
| R&D | $7.4M | $7.7M | $7.5M | $9.4M | $9.9M | $15.3M | $14.7M | $14.4M | $16.2M | $21.0M |
| Frais Généraux | $4.2M | $7.8M | $7.9M | $7.9M | $12.4M | $18.0M | $17.9M | $18.6M | $22.0M | $32.6M |
| Charges Opérationnelles | $16.2M | $19.1M | $15.4M | $17.3M | $22.3M | $33.2M | $35.1M | $33.0M | $38.2M | $53.6M |
| Résultat Opérationnel | -$16.2M | -$17.2M | -$14.8M | -$14.9M | -$18.9M | -$30.3M | -$32.1M | -$28.6M | -$31.5M | -$42.0M |
| EBITDA | -$15.6M | -$16.5M | -$19.5M | -$12.5M | -$19.5M | -$28.6M | -$26.6M | -$26.8M | -$25.6M | -$41.4M |
| Charges d'Intérêt | $615868 | $1.1M | $755374 | $1.0M | $543000 | $66410 | $167105 | $770000 | 0 | 0 |
| Résultat Avant Impôts | -$16.3M | -$18.7M | -$15.1M | -$15.1M | -$21.6M | -$30.6M | -$28.4M | -$28.7M | -$26.5M | -$43.1M |
| Impôts | $14054 | $74123 | $169441 | $147000 | $45000 | $105000 | $287000 | -$128000 | -$1903 | $256411 |
| Résultat Net | -$12.1M | -$19.1M | -$15.2M | -$15.2M | -$21.6M | -$30.7M | -$28.7M | -$28.6M | -$26.5M | -$43.3M |
| BPA | $-3.93 | $-2.44 | $-1.52 | $-1.39 | $-1.25 | $-1.50 | $-1.38 | $-1.35 | $-1.07 | $-1.43 |
| BPA Dilué | $-3.93 | $-2.44 | $-1.52 | $-1.39 | $-1.25 | $-1.50 | $-1.38 | $-1.35 | $-1.07 | $-1.43 |
| Actions en Circulation (Diluées) | $4.2M | $6.1M | $10.0M | $11.1M | $17.3M | $20.5M | $20.8M | $21.2M | $24.8M | $30.2M |
Prix
| Prix | $5.89 |
| Capitalisation | $214M |
| Bourse | NASDAQ |
| Pays | CA |
Entreprises liées: ARMP · AVR · CATX · LNSR · MXCT · NNOX · OWLT
Explorer le secteur: Healthcare · Medical - Devices
Plus de sections de PROF: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions